Occurrence of multiple sclerosis in central Finland:: a regional and temporal comparison during 30 years

被引:45
|
作者
Sarasoja, T
Wikström, J
Paltamaa, J
Hakama, M
Sumelahti, ML
机构
[1] Univ Tampere, Sch Publ Hlth, Tampere 33101, Finland
[2] Cent Hosp Cent Finland, Dept Neurol, Jyvaskyla, Finland
[3] Helsinki Univ Hosp, Dept Neurol, FIN-00170 Helsinki, Finland
[4] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
来源
ACTA NEUROLOGICA SCANDINAVICA | 2004年 / 110卷 / 05期
关键词
multiple sclerosis; incidence; prevalence; diagnosis;
D O I
10.1111/j.1600-0404.2004.00326.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective - We estimated the prevalence and incidence of multiple sclerosis (MS) in central Finland up to 2000. Rates were compared with those in other areas in Finland. Material and method - MS cases were identified in the hospital registry by ICD codes for demyelinating diseases from 1979 to 2000. Cases with definite MS were included. Incidence and prevalence were calculated with 95% CI and standardization was performed using direct method. Results - In 1993 prevalence was 59/10(5) (n = 153). Incidence in 1979-93 was 3.8/10(5) person-years (n = 126). Rates are similar to average in areas with known rates of MS in Finland but substantially less than the over twofold MS risk in the neighbouring district Seinajoki. Extended follow-up to 2000 in central Finland showed increasing prevalence up to 105/10(5) (n = 277) and a significant increase in incidence 1994-98 up to 9.2/10(5) (n = 105). At the same time the diagnostic use of MRI increased up to 97%. Conclusion - Central Finland represents an average risk area of MS when compared with other areas of Finland but still a high risk in global comparison. The recent rapid increase in both prevalence and incidence is largely accounted for by increased use of MRI.
引用
收藏
页码:331 / 336
页数:6
相关论文
共 46 条
  • [31] Comparison Between Isometric and Concentric Motor Fatigability in Persons With Multiple Sclerosis and Healthy Controls - exploring central and peripheral contributions of motor fatigability
    Gaemelke, Tobias
    Riemenschneider, Morten
    Dalgas, Ulrik
    Kjolhede, Tue
    Rasmussen, Cuno
    Stenager, Egon
    Overgaard, Kristian
    Hvid, Lars G.
    NEUROREHABILITATION AND NEURAL REPAIR, 2021, 35 (07) : 644 - 653
  • [32] Cannabis use during adolescence and the occurrence of depression, suicidality and anxiety disorder across adulthood: Findings from a longitudinal cohort study over 30 years
    Hengartner, Michael P.
    Angst, Jules
    Ajdacic-Gross, Vladeta
    Roessler, Wulf
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 272 : 98 - 103
  • [33] Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977-2015: A nationwide population-based incidence study
    Boesen, Magnus Spangsberg
    Magyari, Melinda
    Koch-Henriksen, Nils
    Thygesen, Lau Caspar
    Born, Alfred Peter
    Uldall, Peter Vilhelm
    Blinkenberg, Morten
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (08) : 1077 - 1086
  • [34] Adherence to Therapy in Multiple Sclerosis and Schizophrenia A Comparison of Adherence and Approaches for its Improvement in the Treatment of two Relapsing Chronic Diseases of the Central Nervous System
    Bussfeld, P.
    Czekalla, J.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2010, 78 (03) : 139 - 146
  • [35] Evaluation of Prolonged Walking in Persons with Multiple Sclerosis: Reliability of the Spatio-Temporal Walking Variables during the 6-Minute Walk Test
    Hadouiri, Nawale
    Monnet, Elisabeth
    Gouelle, Arnaud
    Decavel, Pierre
    Sagawa, Yoshimasa
    SENSORS, 2021, 21 (09)
  • [36] Evaluation of clinical parameters during and after treatment of attack in patients with clinically isolated syndrome: Comparison of the results with that of multiple sclerosis patients
    Cinar, Bilge Piri
    Ozakbas, Serkan
    Idiman, Egemen
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (12) : 2432 - 2437
  • [37] Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics
    Vidal-Jordana, Angela
    Sastre-Garriga, Jaume
    Perez-Miralles, Francisco
    Pareto, Deborah
    Rio, Jordi
    Auger, Cristina
    Tintore, Mar
    Rovira, Alex
    Montalban, Xavier
    JOURNAL OF NEUROIMAGING, 2016, 26 (05) : 532 - 538
  • [38] The Sit-to-Stand Transition as a Biomarker for Impairment: Comparison of Instrumented 30-Second Chair Stand Test and Daily Life Transitions in Multiple Sclerosis
    Tulipani, Lindsey J.
    Meyer, Brett
    Fox, Samantha
    Solomon, Andrew J.
    Mcginnis, Ryan S.
    IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING, 2022, 30 : 1213 - 1222
  • [39] Effect of the time of day on central and peripheral fatigue during 2-min maximal voluntary contractions in persons with multiple sclerosis: gender differences
    Streckis, Vytautas
    Skurvydas, Albertas
    Mamkus, Gediminas
    JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY, 2014, 24 (05) : 601 - 606
  • [40] The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution
    Cuzner, ML
    Gveric, D
    Strand, C
    Loughlin, AJ
    Paemen, L
    Opdenakker, G
    Newcombe, J
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (12) : 1194 - 1204